We’re thrilled to announce that Skymab has been awarded a Pfizer Golden Ticket at Paris BioLabs! This prestigious recognition underscores our innovative work in advancing antibody-drug conjugates (ADCs). We’re excited to leverage this opportunity to further accelerate our research and collaboration efforts. Join us in celebrating this milestone!